SlideShare a Scribd company logo
Risk Communication in
   the 21st Century

         Ragnar Löfstedt
      Professor and Director
  King’s Centre for Risk Management
       King’s College, London

            Classified - Internal use   1
In this talk I will:
 Provide a definition of Risk Communication and put it
 in context with examples
 Describe how we in Europe have moved from an old
 consensus model to a new more transparent
 deliberative model of regulation
 Summarise some of the teething problems associated
 with this new model
 Describe what may happen with the new model of
 regulation over a 5-10 year period
 Finally, offer some possible solutions to the teething
 problems


                    Classified - Internal use         2
Introduction to Risk Communication:
  Field has its origins in risk perception
  (Fischhoff, Slovic, Lichtenstein)

  People viewed risks differently:
    Natural – Technological
    Voluntary – Involuntary
    Familiar – Non Familiar
    Control – Non Control
    High Frequency/Low Consequence Risk VS
    Low Frequency/High Consequence Risk
    Female - Male

                     Classified - Internal use   3
Introduction to Risk Communication:

  Based on these findings, regulators and
  industry took the view that one should
  develop risk communication programmes

    Build nuclear power plants
    Site nuclear waste facilities
    Build waste incinerators
    Convince publics that certain foods are safe




                      Classified - Internal use    4
Introduction to Risk Communication:

  Three risk communications strategies put
  forward:

    Top-down
    Dialogue
    Bottom-up




                   Classified - Internal use   5
Introduction to Risk Communication:

  Risk communication still difficult to do!

    Social / Amplifications / Attenuations
    Narrative
    Trust / No trust




                      Classified - Internal use   6
Introduction to Risk Communication:
Over the years, risk communication efforts have
experienced both successes and failures:
 Failures
    Swedish (2002) acrylamide scare
    Shell – Brent Spar oil storage buoy
    US Dept of Energy – siting nuclear waste storage
    facility
 Successes
    UK – FSA building trust post-BSE
    Johnson & Johnson – Tylenol scare
    Sweden-EON – Barseback nuclear power plant
    incident
                     Classified - Internal use         7
Policy background:
European’s have had their fair share of
regulatory “scandals”, emanating both from real
or perceived health issues:
   Dioxins in Belgian chicken feed
   Tainted blood in France
   Mad Cow disease in UK and elsewhere
   Foot and Mouth Disease
   The UK MMR fiasco


Led to public distrust towards policy makers
                   Classified - Internal use      8
Led to a change in the making of
regulation from:
     * Old “consensus” model:
  Policymakers and industry met behind closed
doors and made regulatory decisions.
  Elitist in nature because meetings involved
heads of industry, senior representatives from
unions, etc.
  Scientists had important role to play outlining
the pros and cons of regulatory actions for elites.
  Citizen and stakeholder groups rarely
consulted.

                   Classified - Internal use    9
To a new model based on:
Greater public and stakeholder participation
   Greater consideration for environmental and
 social values
Greater transparency in regulatory strategies and
 decisions
  More accountability of the regulator
Greater use of precaution
  The role of Science is downplayed, as scientific results are
  increasingly under scrutiny - scientists seen as just another
  stakeholder
  The role of Media is enhanced


   Distrust of “old” regulators = rise of “new”
                        regulators
                   Classified - Internal use   10
A number of teething problems
Greater public and stakeholder participation
   Self selection process
      GM Nation?
      North Black Forest (3.5% participated)
  Involving stakeholders can lead to greater
public trust
   Stakeholders are also listened to
   Feel ownership of the outcome
    YET involving stakeholders can lead to
  decrease in public trust
   NGOs may have separate agendas
      Swedish Chemical Inspectorate example


                          Classified - Internal use   11
A number of teething problems (cont.)

Open and Transparent Regulatory Practices
  Seen as a need, as many regulatory scandals are
caused by lack of transparency

    However, transparency can also lead to:
   Outsourcing of risk communication
   Public having to make their own decisions




                      Classified - Internal use   12
Transparency leads to policy vacuums
(old days there was a consensus)
  Regulators are slow off their feet (fire
fighting)
 However, transparency can also lead to:
    NGOs issue managers
    Transparency leads to scientific pluralism




                    Classified - Internal use     13
New model: use of the precautionary
principle and growth of risk aversion

  New scandal around the corner - better safe
than sorry
 In some cases, over regulation prevails
Commission's decision to ban imports of ground
nuts
 Leads to problems associated with risk-risk
paradigm


                  Classified - Internal use     14
Role of Science




   Classified - Internal use   15
The “rise” of the new regulators
Aspartame case: Ramazzini Foundation (RF) July 2005
press conference noting that aspartame causes cancer in rats

  RF refused to share data with EFSA
    Amplified the scare
       Continued press conferences
       Press releases
       Interviews with the media
  Media Vacuum Occurs
    Secondary amplification
       Campaign groups
       Activist journalists
  EFSA May 06 holds press conference
    Research not peer reviewed
    No dose response relationship aspartame-cancer
    Rats may have been ill to begin with
                               Classified - Internal use   16
Aspartame (cont.)
Outcome: ”un-ethical” amplification of a risk
 Negatively impacted perceptions of aspartame among media,
  stakeholders, and eventually consumers
 Caused 40% reduction of table top aspartame usage in
  many countries-e.g. France
 Deprives the overweight and obese, and more critically so
  the diabetics, of healthy alternatives for sweet taste
Key take-aways:
 Media needs to become a more responsible communicator
 Lack of transparency can lead to communication vacuum
 There were no credible science organisations able to
  refute findings early on
 Showed further problems with the new model of
  regulation
                    Classified - Internal use         17
Role of Media
  As pointed out with the Ramazzini study, it is obvious that
the role of the media is critical in properly
communicating health information, so as not to cause
panic and unsubstantiated reaction.

  The following slides provide a ‘case study’ on their role
in “mis-presenting” health information and in
creating and amplifying a health scare.




                        Classified - Internal use         18
An article published in The Guardian
                            in 2005, reflects other news articles
                            published at the time into the
                            Ramazzini Foundation Study into
                            Aspartame, which found it caused
                            kidney cancer and was linked to
                            other cancers. The study has since
                            been discredited, but is nonetheless
                            regularly featured in any current
                            coverage on the subject of low-
                            calorie sweeteners.




Classified - Internal use
This article, posted on the BBC News website in late 2009 uses the launch
of a FSA study into Aspartame to publish and article on concerns over the
side effects of consuming the sweetener. Although more balanced in tone,
it repeated previous concerns linking Aspartame to cancer, fertility issues
etc displaying how easy it is for old claims (and inaccurate) to resurface.


                             Classified - Internal use
Looking at the safety of low-calorie sweeteners in particular, this story ran in
The Daily Mail in May 2011 providing details of a EU review into the safety of
Aspartame. The review gave the media a platform to repeat old and disputed
claims about the safety of Aspartame with minimal balance.

                               Classified - Internal use
In the space of just one week, these three health stories ran as
cover stories in the Daily Express, illustrating what a confusing,
and potentially irresponsible picture even one media outlet can
paint around healthy diet and nutrition habits.




                            Classified - Internal use
So what will happen? Is the new
 model of regulation here to stay?
Yes, it will.
     Regulators, policy makers and industry will remain
     distrusted by the public at large
     Although public trust levels will vary between
     different ministries and different countries.
     Not all negative-trust levels can rebound
     Yet scandals will remain (particularly in food sectors)

                      Classified - Internal use          23
The precautionary principle as a
  regulatory tool will remain
 Many regulators see it as a convenient tool
(in replace of more expensive and
complicated risk assessments)
 3 recent decisions
  The paraquat (Sweden-European Court of First
   Instance)
  UK FSA’s decision to call for a voluntary ban of azo
   dyes (April 2008)
  EU wide ban of deca-BDE-a brominated flame
   retardant found in electronic appliances

                     Classified - Internal use            24
Policy makers/regulators will do
everything possible to halt dilution of
power
    Deliberation for many will be a façade
    Do not want to work with NGOs

Some countries more ready for the new
model than others
 Small member states will have difficult to cope

Aggressive media will lead to continued
public distrust of policy makers and
regulators
 Export of the “British model” to the rest of
  Europe

                   Classified - Internal use        25
Going Forward & Conclusions
How can we best sort out the teething problems?
Regulators:
  Ensure that regulators and policy makers are prepared
  for the transparency era. Going forward, we will have more
  rather than less transparency; presently they are not ready.
  Develop rigorous models-frameworks for where the
  precautionary principle should and should not be used -
  good example is the European Commission’s communication on
  the topic from 2000
  Fund more research in how to make deliberation best
  work - how can we move away from the self selection process?
  Ensure that communication director within a regulatory
  agency is part of the executive function

                        Classified - Internal use         26
Conclusions (cont.)
Science:
  Promote independent scientific advice - with the
caveat that this will require government to become a
larger funder of university departments
  Promote the establishment of a genuine European
academy of sciences - set up specifically to reduce
scientific uncertainty

Media:
 The establishment of some form of media
guidelines to ensure that media does not
unnecessarily amplify risks that in many cases should
be attenuated-and communicate numbers accurately

                     Classified - Internal use     27

More Related Content

What's hot

Environmental Management
Environmental ManagementEnvironmental Management
Environmental Management
Dominic Mutambu
 
Chapter 2 (crisis management)
Chapter 2 (crisis management)Chapter 2 (crisis management)
Chapter 2 (crisis management)
Abdul Jawad Chaudhry
 
Risk Perception and Communication
Risk Perception and CommunicationRisk Perception and Communication
Risk Perception and Communication
OECD Governance
 
Risk communication
Risk communicationRisk communication
Risk communication
claudiu1980
 
Risk Management Process And Procedures PowerPoint Presentation Slides
Risk Management Process And Procedures PowerPoint Presentation SlidesRisk Management Process And Procedures PowerPoint Presentation Slides
Risk Management Process And Procedures PowerPoint Presentation Slides
SlideTeam
 
Risk and Crisis Communication CERC
Risk and Crisis Communication CERCRisk and Crisis Communication CERC
Risk and Crisis Communication CERC
Ahmed-Refat Refat
 
COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)
COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)
COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)
Devin DeCiantis
 
Enviromental risk assessment
Enviromental risk assessmentEnviromental risk assessment
Enviromental risk assessment
Nabin Lamichhane
 
Risk perception: thinking vs. feeling
Risk perception: thinking vs. feelingRisk perception: thinking vs. feeling
Risk perception: thinking vs. feeling
Rusty Cawley, APR
 
An Introduction to Risk Management for Healthcare Institution - ROJoson
An Introduction to Risk Management for Healthcare Institution - ROJosonAn Introduction to Risk Management for Healthcare Institution - ROJoson
An Introduction to Risk Management for Healthcare Institution - ROJoson
Reynaldo Joson
 
Risk Analysis
Risk AnalysisRisk Analysis
Risk Analysis
Nishodh Saxena Ph. D.
 
Crisis And Risk
Crisis And RiskCrisis And Risk
Crisis And Risk
kktv
 
19b crisis management
19b crisis management19b crisis management
19b crisis management
Atul Kesharwani
 
IATA safety culture from the top down
IATA safety culture from the top downIATA safety culture from the top down
IATA safety culture from the top down
DigitalPower
 
Social determinant of health
Social determinant of healthSocial determinant of health
Social determinant of health
lamiaa Gamal
 
Disaster Risk Reduction
Disaster Risk ReductionDisaster Risk Reduction
Risk assessment presentation
Risk assessment presentationRisk assessment presentation
Risk assessment presentation
mmagario
 
Principles of disater management
Principles of disater managementPrinciples of disater management
Principles of disater management
ANUP SINGH
 
Communication in crisis situations
Communication in crisis situationsCommunication in crisis situations
Risk management
Risk managementRisk management
Risk management
Bebura Matanda
 

What's hot (20)

Environmental Management
Environmental ManagementEnvironmental Management
Environmental Management
 
Chapter 2 (crisis management)
Chapter 2 (crisis management)Chapter 2 (crisis management)
Chapter 2 (crisis management)
 
Risk Perception and Communication
Risk Perception and CommunicationRisk Perception and Communication
Risk Perception and Communication
 
Risk communication
Risk communicationRisk communication
Risk communication
 
Risk Management Process And Procedures PowerPoint Presentation Slides
Risk Management Process And Procedures PowerPoint Presentation SlidesRisk Management Process And Procedures PowerPoint Presentation Slides
Risk Management Process And Procedures PowerPoint Presentation Slides
 
Risk and Crisis Communication CERC
Risk and Crisis Communication CERCRisk and Crisis Communication CERC
Risk and Crisis Communication CERC
 
COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)
COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)
COVID-19 Crisis Management Toolkit for Family Business (Executive Summary)
 
Enviromental risk assessment
Enviromental risk assessmentEnviromental risk assessment
Enviromental risk assessment
 
Risk perception: thinking vs. feeling
Risk perception: thinking vs. feelingRisk perception: thinking vs. feeling
Risk perception: thinking vs. feeling
 
An Introduction to Risk Management for Healthcare Institution - ROJoson
An Introduction to Risk Management for Healthcare Institution - ROJosonAn Introduction to Risk Management for Healthcare Institution - ROJoson
An Introduction to Risk Management for Healthcare Institution - ROJoson
 
Risk Analysis
Risk AnalysisRisk Analysis
Risk Analysis
 
Crisis And Risk
Crisis And RiskCrisis And Risk
Crisis And Risk
 
19b crisis management
19b crisis management19b crisis management
19b crisis management
 
IATA safety culture from the top down
IATA safety culture from the top downIATA safety culture from the top down
IATA safety culture from the top down
 
Social determinant of health
Social determinant of healthSocial determinant of health
Social determinant of health
 
Disaster Risk Reduction
Disaster Risk ReductionDisaster Risk Reduction
Disaster Risk Reduction
 
Risk assessment presentation
Risk assessment presentationRisk assessment presentation
Risk assessment presentation
 
Principles of disater management
Principles of disater managementPrinciples of disater management
Principles of disater management
 
Communication in crisis situations
Communication in crisis situationsCommunication in crisis situations
Communication in crisis situations
 
Risk management
Risk managementRisk management
Risk management
 

Similar to Risk Communication in the 21st Century

OECD Workshop: Learning from crises and fostering the continuous improvement...
 OECD Workshop: Learning from crises and fostering the continuous improvement... OECD Workshop: Learning from crises and fostering the continuous improvement...
OECD Workshop: Learning from crises and fostering the continuous improvement...
OECD Governance
 
Erik Millstone Food Thinker September 2016
Erik Millstone Food Thinker September 2016Erik Millstone Food Thinker September 2016
Erik Millstone Food Thinker September 2016
FoodResearchCollaboration
 
EPAF final
EPAF finalEPAF final
EPAF final
FEChair
 
European Policy Audit on Fertility
European Policy Audit on Fertility European Policy Audit on Fertility
European Policy Audit on Fertility
Asociatia SOS Infertilitatea - www.vremcopii.ro
 
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMIPistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance
 
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...
Global Bridges
 
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...
Jim Bloyd, DrPH, MPH
 
History and progress of pharmacovigilance
History and progress of pharmacovigilanceHistory and progress of pharmacovigilance
History and progress of pharmacovigilance
Gagandeep Jaiswal
 
Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...
MeTApresents
 
HCF 2018 Panel 2: Martin Kayser
HCF 2018 Panel 2: Martin KayserHCF 2018 Panel 2: Martin Kayser
HCF 2018 Panel 2: Martin Kayser
Chemicals Forum Association
 
Hidden Hazards of Air Fresheners
Hidden Hazards of Air Fresheners Hidden Hazards of Air Fresheners
Hidden Hazards of Air Fresheners
v2zq
 
Australia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample ReportAustralia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample Report
Insights10
 
Late lessons from early warnings: the precautionary principle 1896–2000
Late lessons from early warnings: the precautionary principle 1896–2000 Late lessons from early warnings: the precautionary principle 1896–2000
Late lessons from early warnings: the precautionary principle 1896–2000
morosini1952
 
Randomized trials of rrvtv vaccine a controversial issue
Randomized trials of rrvtv  vaccine        a  controversial issueRandomized trials of rrvtv  vaccine        a  controversial issue
Randomized trials of rrvtv vaccine a controversial issue
Xiomara Arias Fernandez
 
OxfordSM's pharma case studies - providing a call to action
OxfordSM's pharma case studies - providing a call to actionOxfordSM's pharma case studies - providing a call to action
OxfordSM's pharma case studies - providing a call to action
OxfordSM
 
Go8 Road to Recovery
Go8 Road to RecoveryGo8 Road to Recovery
Go8 Road to Recovery
Turlough Guerin GAICD FGIA
 
The exposome and work
The exposome and workThe exposome and work
The exposome and work
Retired
 
Risk assessment of pharmacueticals
Risk assessment of pharmacueticalsRisk assessment of pharmacueticals
Risk assessment of pharmacueticals
lmoench
 
CARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdf
CARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdfCARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdf
CARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdf
AbhilipsaSahoo4
 
Where there is no vision the people perish
Where there is no vision the people perishWhere there is no vision the people perish
Where there is no vision the people perish
John Middleton
 

Similar to Risk Communication in the 21st Century (20)

OECD Workshop: Learning from crises and fostering the continuous improvement...
 OECD Workshop: Learning from crises and fostering the continuous improvement... OECD Workshop: Learning from crises and fostering the continuous improvement...
OECD Workshop: Learning from crises and fostering the continuous improvement...
 
Erik Millstone Food Thinker September 2016
Erik Millstone Food Thinker September 2016Erik Millstone Food Thinker September 2016
Erik Millstone Food Thinker September 2016
 
EPAF final
EPAF finalEPAF final
EPAF final
 
European Policy Audit on Fertility
European Policy Audit on Fertility European Policy Audit on Fertility
European Policy Audit on Fertility
 
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMIPistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
 
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...
The Critical Importance of Health Care Worker Leadership in the Tobacco Contr...
 
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...
Public Health, Politics, and the Creation of Meaning: A Public Health of Cons...
 
History and progress of pharmacovigilance
History and progress of pharmacovigilanceHistory and progress of pharmacovigilance
History and progress of pharmacovigilance
 
Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...
 
HCF 2018 Panel 2: Martin Kayser
HCF 2018 Panel 2: Martin KayserHCF 2018 Panel 2: Martin Kayser
HCF 2018 Panel 2: Martin Kayser
 
Hidden Hazards of Air Fresheners
Hidden Hazards of Air Fresheners Hidden Hazards of Air Fresheners
Hidden Hazards of Air Fresheners
 
Australia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample ReportAustralia Lung Cancer Drugs Market Analysis Sample Report
Australia Lung Cancer Drugs Market Analysis Sample Report
 
Late lessons from early warnings: the precautionary principle 1896–2000
Late lessons from early warnings: the precautionary principle 1896–2000 Late lessons from early warnings: the precautionary principle 1896–2000
Late lessons from early warnings: the precautionary principle 1896–2000
 
Randomized trials of rrvtv vaccine a controversial issue
Randomized trials of rrvtv  vaccine        a  controversial issueRandomized trials of rrvtv  vaccine        a  controversial issue
Randomized trials of rrvtv vaccine a controversial issue
 
OxfordSM's pharma case studies - providing a call to action
OxfordSM's pharma case studies - providing a call to actionOxfordSM's pharma case studies - providing a call to action
OxfordSM's pharma case studies - providing a call to action
 
Go8 Road to Recovery
Go8 Road to RecoveryGo8 Road to Recovery
Go8 Road to Recovery
 
The exposome and work
The exposome and workThe exposome and work
The exposome and work
 
Risk assessment of pharmacueticals
Risk assessment of pharmacueticalsRisk assessment of pharmacueticals
Risk assessment of pharmacueticals
 
CARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdf
CARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdfCARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdf
CARCINOGENS-REVIEW-PDF-JUNE2017 (1).pdf
 
Where there is no vision the people perish
Where there is no vision the people perishWhere there is no vision the people perish
Where there is no vision the people perish
 

More from AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit

Kleiner Bienenstockkäfer in Italien nachgewiesen
Kleiner Bienenstockkäfer in Italien nachgewiesenKleiner Bienenstockkäfer in Italien nachgewiesen
Kleiner Bienenstockkäfer in Italien nachgewiesen
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...
Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...
Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
AGES West Nil Folder
AGES West Nil FolderAGES West Nil Folder
"Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens...
"Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens..."Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens...
"Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
"Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und...
"Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und..."Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und...
"Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...
Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...
Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...
Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...
Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...
Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...
Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015
Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015 Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015
Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...
AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...
AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
AGES presentation of the Division of Public Health at Meeting with ECDC
AGES presentation of the Division of Public Health at Meeting with ECDCAGES presentation of the Division of Public Health at Meeting with ECDC
AGES presentation of the Division of Public Health at Meeting with ECDC
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...
MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...
MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)
„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)
„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
"Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe...
"Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe..."Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe...
"Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
"Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko...
"Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko..."Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko...
"Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
„Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET)
„Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET) „Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET)
„Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET)
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)
„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)
„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)
„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)
„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 
„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...
„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...
„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...
AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit
 

More from AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit (20)

Kleiner Bienenstockkäfer in Italien nachgewiesen
Kleiner Bienenstockkäfer in Italien nachgewiesenKleiner Bienenstockkäfer in Italien nachgewiesen
Kleiner Bienenstockkäfer in Italien nachgewiesen
 
Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...
Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...
Josef Mayr zu Zwischenergebnissen des Projektes Bioenergy-Silphium und Beflug...
 
Vortrag: "Pflanzenschutzmittel - Fakten statt Hysterie", Dr. Albert Bergmann ...
Vortrag: "Pflanzenschutzmittel - Fakten statt Hysterie", Dr. Albert Bergmann ...Vortrag: "Pflanzenschutzmittel - Fakten statt Hysterie", Dr. Albert Bergmann ...
Vortrag: "Pflanzenschutzmittel - Fakten statt Hysterie", Dr. Albert Bergmann ...
 
AGES West Nil Folder
AGES West Nil FolderAGES West Nil Folder
AGES West Nil Folder
 
"Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens...
"Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens..."Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens...
"Verkaufsdaten von Veterinärantibiotika in 25 europäischen Staaten" - Klemens...
 
"Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und...
"Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und..."Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und...
"Präsentation des Resistenberichts AURES 2012", Petra Apfalter (NRZ Linz) und...
 
Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...
Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...
Peter Hufnagl zur Public Health-Bedeutung von Neobiota: "Gelsenmonitoring in ...
 
Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...
Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...
Swen Follak zu gesundheitlicher Bedeutung allergener Neobiota: "Ausbreitungsd...
 
Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...
Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...
Rudolf Moosbeckhofer zu Neobiota: "Bienengesundheit im Zusammenhang mit einge...
 
Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015
Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015 Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015
Vom Input zum Impact: Entwicklung der AGES 2002 bis 2015
 
AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...
AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...
AGES Austrian Agency for Health and Food Safety - RESEARCH FOCUS presentation...
 
AGES presentation of the Division of Public Health at Meeting with ECDC
AGES presentation of the Division of Public Health at Meeting with ECDCAGES presentation of the Division of Public Health at Meeting with ECDC
AGES presentation of the Division of Public Health at Meeting with ECDC
 
MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...
MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...
MELISSA: Investigations in the incidence of bee losses in corn and oilseed ra...
 
„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)
„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)
„Listerien in Lebensmitteln in Österreich“ – Ariane PIETZKA (AGES Graz)
 
"Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe...
"Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe..."Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe...
"Vector-borne diseases in Österreich" - Friedrich Schmoll (AGES, Tiergesundhe...
 
"Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko...
"Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko..."Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko...
"Health claims aus Sicht der amtlichen Lebensmittelkontrolle" - Markus Zsivko...
 
„Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET)
„Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET) „Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET)
„Listeriose bei Säugetieren in Österreich“ - Zoltan Bago (AGES, IVET)
 
„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)
„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)
„Listeriose beim Menschen in Österreich“ - Franz Allerberger (AGES)
 
„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)
„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)
„Listerien in Fischprodukten“ - Marija Zunabovic & Konrad J. Domig (BoKu, Wien)
 
„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...
„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...
„Lebensmittelsicherheit in der EU: Verantwortung des Herstellers oder der Beh...
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 

Risk Communication in the 21st Century

  • 1. Risk Communication in the 21st Century Ragnar Löfstedt Professor and Director King’s Centre for Risk Management King’s College, London Classified - Internal use 1
  • 2. In this talk I will: Provide a definition of Risk Communication and put it in context with examples Describe how we in Europe have moved from an old consensus model to a new more transparent deliberative model of regulation Summarise some of the teething problems associated with this new model Describe what may happen with the new model of regulation over a 5-10 year period Finally, offer some possible solutions to the teething problems Classified - Internal use 2
  • 3. Introduction to Risk Communication: Field has its origins in risk perception (Fischhoff, Slovic, Lichtenstein) People viewed risks differently: Natural – Technological Voluntary – Involuntary Familiar – Non Familiar Control – Non Control High Frequency/Low Consequence Risk VS Low Frequency/High Consequence Risk Female - Male Classified - Internal use 3
  • 4. Introduction to Risk Communication: Based on these findings, regulators and industry took the view that one should develop risk communication programmes Build nuclear power plants Site nuclear waste facilities Build waste incinerators Convince publics that certain foods are safe Classified - Internal use 4
  • 5. Introduction to Risk Communication: Three risk communications strategies put forward: Top-down Dialogue Bottom-up Classified - Internal use 5
  • 6. Introduction to Risk Communication: Risk communication still difficult to do! Social / Amplifications / Attenuations Narrative Trust / No trust Classified - Internal use 6
  • 7. Introduction to Risk Communication: Over the years, risk communication efforts have experienced both successes and failures: Failures Swedish (2002) acrylamide scare Shell – Brent Spar oil storage buoy US Dept of Energy – siting nuclear waste storage facility Successes UK – FSA building trust post-BSE Johnson & Johnson – Tylenol scare Sweden-EON – Barseback nuclear power plant incident Classified - Internal use 7
  • 8. Policy background: European’s have had their fair share of regulatory “scandals”, emanating both from real or perceived health issues: Dioxins in Belgian chicken feed Tainted blood in France Mad Cow disease in UK and elsewhere Foot and Mouth Disease The UK MMR fiasco Led to public distrust towards policy makers Classified - Internal use 8
  • 9. Led to a change in the making of regulation from: * Old “consensus” model: Policymakers and industry met behind closed doors and made regulatory decisions. Elitist in nature because meetings involved heads of industry, senior representatives from unions, etc. Scientists had important role to play outlining the pros and cons of regulatory actions for elites. Citizen and stakeholder groups rarely consulted. Classified - Internal use 9
  • 10. To a new model based on: Greater public and stakeholder participation Greater consideration for environmental and social values Greater transparency in regulatory strategies and decisions More accountability of the regulator Greater use of precaution The role of Science is downplayed, as scientific results are increasingly under scrutiny - scientists seen as just another stakeholder The role of Media is enhanced Distrust of “old” regulators = rise of “new” regulators Classified - Internal use 10
  • 11. A number of teething problems Greater public and stakeholder participation  Self selection process  GM Nation?  North Black Forest (3.5% participated) Involving stakeholders can lead to greater public trust  Stakeholders are also listened to  Feel ownership of the outcome YET involving stakeholders can lead to decrease in public trust  NGOs may have separate agendas  Swedish Chemical Inspectorate example Classified - Internal use 11
  • 12. A number of teething problems (cont.) Open and Transparent Regulatory Practices Seen as a need, as many regulatory scandals are caused by lack of transparency However, transparency can also lead to:  Outsourcing of risk communication  Public having to make their own decisions Classified - Internal use 12
  • 13. Transparency leads to policy vacuums (old days there was a consensus) Regulators are slow off their feet (fire fighting) However, transparency can also lead to:  NGOs issue managers  Transparency leads to scientific pluralism Classified - Internal use 13
  • 14. New model: use of the precautionary principle and growth of risk aversion New scandal around the corner - better safe than sorry In some cases, over regulation prevails Commission's decision to ban imports of ground nuts Leads to problems associated with risk-risk paradigm Classified - Internal use 14
  • 15. Role of Science Classified - Internal use 15
  • 16. The “rise” of the new regulators Aspartame case: Ramazzini Foundation (RF) July 2005 press conference noting that aspartame causes cancer in rats RF refused to share data with EFSA  Amplified the scare  Continued press conferences  Press releases  Interviews with the media Media Vacuum Occurs  Secondary amplification  Campaign groups  Activist journalists EFSA May 06 holds press conference  Research not peer reviewed  No dose response relationship aspartame-cancer  Rats may have been ill to begin with Classified - Internal use 16
  • 17. Aspartame (cont.) Outcome: ”un-ethical” amplification of a risk  Negatively impacted perceptions of aspartame among media, stakeholders, and eventually consumers  Caused 40% reduction of table top aspartame usage in many countries-e.g. France  Deprives the overweight and obese, and more critically so the diabetics, of healthy alternatives for sweet taste Key take-aways:  Media needs to become a more responsible communicator  Lack of transparency can lead to communication vacuum  There were no credible science organisations able to refute findings early on  Showed further problems with the new model of regulation Classified - Internal use 17
  • 18. Role of Media As pointed out with the Ramazzini study, it is obvious that the role of the media is critical in properly communicating health information, so as not to cause panic and unsubstantiated reaction. The following slides provide a ‘case study’ on their role in “mis-presenting” health information and in creating and amplifying a health scare. Classified - Internal use 18
  • 19. An article published in The Guardian in 2005, reflects other news articles published at the time into the Ramazzini Foundation Study into Aspartame, which found it caused kidney cancer and was linked to other cancers. The study has since been discredited, but is nonetheless regularly featured in any current coverage on the subject of low- calorie sweeteners. Classified - Internal use
  • 20. This article, posted on the BBC News website in late 2009 uses the launch of a FSA study into Aspartame to publish and article on concerns over the side effects of consuming the sweetener. Although more balanced in tone, it repeated previous concerns linking Aspartame to cancer, fertility issues etc displaying how easy it is for old claims (and inaccurate) to resurface. Classified - Internal use
  • 21. Looking at the safety of low-calorie sweeteners in particular, this story ran in The Daily Mail in May 2011 providing details of a EU review into the safety of Aspartame. The review gave the media a platform to repeat old and disputed claims about the safety of Aspartame with minimal balance. Classified - Internal use
  • 22. In the space of just one week, these three health stories ran as cover stories in the Daily Express, illustrating what a confusing, and potentially irresponsible picture even one media outlet can paint around healthy diet and nutrition habits. Classified - Internal use
  • 23. So what will happen? Is the new model of regulation here to stay? Yes, it will. Regulators, policy makers and industry will remain distrusted by the public at large Although public trust levels will vary between different ministries and different countries. Not all negative-trust levels can rebound Yet scandals will remain (particularly in food sectors) Classified - Internal use 23
  • 24. The precautionary principle as a regulatory tool will remain Many regulators see it as a convenient tool (in replace of more expensive and complicated risk assessments) 3 recent decisions  The paraquat (Sweden-European Court of First Instance)  UK FSA’s decision to call for a voluntary ban of azo dyes (April 2008)  EU wide ban of deca-BDE-a brominated flame retardant found in electronic appliances Classified - Internal use 24
  • 25. Policy makers/regulators will do everything possible to halt dilution of power  Deliberation for many will be a façade  Do not want to work with NGOs Some countries more ready for the new model than others  Small member states will have difficult to cope Aggressive media will lead to continued public distrust of policy makers and regulators  Export of the “British model” to the rest of Europe Classified - Internal use 25
  • 26. Going Forward & Conclusions How can we best sort out the teething problems? Regulators: Ensure that regulators and policy makers are prepared for the transparency era. Going forward, we will have more rather than less transparency; presently they are not ready. Develop rigorous models-frameworks for where the precautionary principle should and should not be used - good example is the European Commission’s communication on the topic from 2000 Fund more research in how to make deliberation best work - how can we move away from the self selection process? Ensure that communication director within a regulatory agency is part of the executive function Classified - Internal use 26
  • 27. Conclusions (cont.) Science: Promote independent scientific advice - with the caveat that this will require government to become a larger funder of university departments Promote the establishment of a genuine European academy of sciences - set up specifically to reduce scientific uncertainty Media: The establishment of some form of media guidelines to ensure that media does not unnecessarily amplify risks that in many cases should be attenuated-and communicate numbers accurately Classified - Internal use 27